BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1291 related articles for article (PubMed ID: 31480898)

  • 21. Comparison of Predictors of Heart Failure With Preserved Versus Reduced Ejection Fraction in a Multiracial Cohort of Preclinical Left Ventricular Diastolic Dysfunction.
    Zhang L; Liebelt JJ; Madan N; Shan J; Taub CC
    Am J Cardiol; 2017 Jun; 119(11):1815-1820. PubMed ID: 28450040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure.
    Savarese G; Vedin O; D'Amario D; Uijl A; Dahlström U; Rosano G; Lam CSP; Lund LH
    JACC Heart Fail; 2019 Apr; 7(4):306-317. PubMed ID: 30852236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heart failure progression and mortality in atrial fibrillation patients with preserved or reduced left ventricular ejection fraction.
    Slee A; Saad M; Saksena S
    J Interv Card Electrophysiol; 2019 Sep; 55(3):325-331. PubMed ID: 30887281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Value of Cardiopulmonary Exercise Testing in Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction.
    Nadruz W; West E; Sengeløv M; Santos M; Groarke JD; Forman DE; Claggett B; Skali H; Shah AM
    J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29089342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comprehensive population-based characterization of heart failure with mid-range ejection fraction.
    Koh AS; Tay WT; Teng THK; Vedin O; Benson L; Dahlstrom U; Savarese G; Lam CSP; Lund LH
    Eur J Heart Fail; 2017 Dec; 19(12):1624-1634. PubMed ID: 28948683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome.
    Farmakis D; Simitsis P; Bistola V; Triposkiadis F; Ikonomidis I; Katsanos S; Bakosis G; Hatziagelaki E; Lekakis J; Mebazaa A; Parissis J
    Clin Res Cardiol; 2017 May; 106(5):359-368. PubMed ID: 27999929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Five-year mortality of heart failure with preserved, mildly reduced, and reduced ejection fraction in a 4880 Chinese cohort.
    Chen S; Huang Z; Liang Y; Zhao X; Aobuliksimu X; Wang B; He Y; Kang Y; Huang H; Li Q; Yao Y; Lu X; Qian X; Xie X; Liu J; Liu Y
    ESC Heart Fail; 2022 Aug; 9(4):2336-2347. PubMed ID: 35437939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential impact of heart rate and blood pressure on outcome in patients with heart failure with reduced versus preserved left ventricular ejection fraction.
    Maeder MT; Kaye DM
    Int J Cardiol; 2012 Mar; 155(2):249-56. PubMed ID: 21035207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatocyte Growth Factor and Incident Heart Failure Subtypes: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Ferraro RA; Ogunmoroti O; Zhao D; Ndumele CE; Rao V; Pandey A; Larson NB; Bielinski SJ; Michos ED
    J Card Fail; 2021 Sep; 27(9):981-990. PubMed ID: 34051347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes.
    Shah KS; Xu H; Matsouaka RA; Bhatt DL; Heidenreich PA; Hernandez AF; Devore AD; Yancy CW; Fonarow GC
    J Am Coll Cardiol; 2017 Nov; 70(20):2476-2486. PubMed ID: 29141781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors and outcomes of heart failure with mid-range ejection fraction.
    Bhambhani V; Kizer JR; Lima JAC; van der Harst P; Bahrami H; Nayor M; de Filippi CR; Enserro D; Blaha MJ; Cushman M; Wang TJ; Gansevoort RT; Fox CS; Gaggin HK; Kop WJ; Liu K; Vasan RS; Psaty BM; Lee DS; Brouwers FP; Hillege HL; Bartz TM; Benjamin EJ; Chan C; Allison M; Gardin JM; Januzzi JL; Levy D; Herrington DM; van Gilst WH; Bertoni AG; Larson MG; de Boer RA; Gottdiener JS; Shah SJ; Ho JE
    Eur J Heart Fail; 2018 Apr; 20(4):651-659. PubMed ID: 29226491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sedentary Time and Cumulative Risk of Preserved and Reduced Ejection Fraction Heart Failure: From the Multi-Ethnic Study of Atherosclerosis.
    Rariden BS; Boltz AJ; Brawner CA; Pinkstaff SO; Richardson MR; Johnson TM; Churilla JR
    J Card Fail; 2019 Jun; 25(6):418-424. PubMed ID: 30930104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes.
    Nadruz W; West E; Santos M; Skali H; Groarke JD; Forman DE; Shah AM
    Circ Heart Fail; 2016 Apr; 9(4):e002826. PubMed ID: 27009553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction.
    Vergaro G; Ghionzoli N; Innocenti L; Taddei C; Giannoni A; Valleggi A; Borrelli C; Senni M; Passino C; Emdin M
    J Am Heart Assoc; 2019 Oct; 8(20):e013441. PubMed ID: 31587602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Diabetes Mellitus on Cardiac Remodeling, Quality of Life, and Clinical Outcomes in Heart Failure With Reduced and Preserved Ejection Fraction.
    Yap J; Tay WT; Teng TK; Anand I; Richards AM; Ling LH; MacDonald MR; Chandramouli C; Tromp J; Siswanto BB; ; Zile M; McMurray J; Lam CSP
    J Am Heart Assoc; 2019 Sep; 8(17):e013114. PubMed ID: 31431116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Causes and Temporal Patterns of 30-Day Readmission Among Older Adults Hospitalized With Heart Failure With Preserved or Reduced Ejection Fraction.
    Goyal P; Loop M; Chen L; Brown TM; Durant RW; Safford MM; Levitan EB
    J Am Heart Assoc; 2018 Apr; 7(9):. PubMed ID: 29686028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycemic Markers and Heart Failure Subtypes: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Echouffo-Tcheugui JB; Ogunmoroti O; Golden SH; Bertoni AG; Mongraw-Chaffin M; Pandey A; Ndumele CE; Michos ED
    J Card Fail; 2022 Nov; 28(11):1593-1603. PubMed ID: 35114382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction.
    Ho JE; Lyass A; Lee DS; Vasan RS; Kannel WB; Larson MG; Levy D
    Circ Heart Fail; 2013 Mar; 6(2):279-86. PubMed ID: 23271790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction.
    Son MK; Park JJ; Lim NK; Kim WH; Choi DJ
    Heart; 2020 Aug; 106(15):1160-1168. PubMed ID: 32341140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
    Sartipy U; Dahlström U; Fu M; Lund LH
    JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 65.